We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 101-120 of 1,316 results
  1. PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine

    Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is indicated for the treatment of major depressive disorder, social anxiety...

    Chang-Keun Cho, Pureum Kang, ... Chang-Ik Choi in Archives of Pharmacal Research
    Article 25 April 2024
  2. Trilaciclib for the reduction of chemotherapy-induced myelosuppression in the management of extensive-stage small cell lung cancer: a profile of its use

    Trilaciclib (COSELA™) is a transient inhibitor of cyclin-dependent kinases 4 and 6 (CDK 4/6) that is approved in the USA to decrease the incidence of...

    Esther S. Kim, Susan J. Keam in Drugs & Therapy Perspectives
    Article 25 January 2022
  3. The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)—preliminary molecular docking analysis

    Background

    The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified at the end of 2019. Despite growing understanding of...

    Krzysztof Marciniec, Artur Beberok, ... Dorota Wrześniok in Pharmacological Reports
    Article Open access 30 May 2021
  4. Platelets in COVID-19 disease: friend, foe, or both?

    Immuno-thrombosis of COVID-19 results in the activation of platelets and coagulopathy. Antiplatelet therapy has been widely used in COVID-19 patients...

    Marta Smęda, Ebrahim Hosseinzadeh Maleki, ... Stefan Chłopicki in Pharmacological Reports
    Article Open access 03 December 2022
  5. Inhibitors of Sortases of Gram-Positive Bacteria and their Role in the Treatment of Infectious Diseases (Review)

    The functions of sortase bacterial enzymes and their surface-protein substrates are reviewed. Their role in the pathogenesis of infectious diseases...

    K. V. Kudryavtsev, T. A. Fedotcheva, N. L. Shimanovsky in Pharmaceutical Chemistry Journal
    Article 18 November 2021
  6. Identification of Novel Peptides Targeting DNA Methyltransferase 1 (DNMT-1) for Breast Cancer Treatment

    Epigenetic alteration shows an essential role in the process of breast cancer cell proliferation and propagation. DNA methyltransferase (DNMT) is...

    Mutiara Saragih, Filia Stephanie, ... Usman S. F. Tambunan in Revista Brasileira de Farmacognosia
    Article 09 September 2020
  7. Don’t Rely on Your Prescription

    Most likely it’s not working for you. When you are prescribed a medicine and take it, you do so in the hope that you will have a benefit from it. Why...
    Chapter 2022
  8. DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson’s disease: a mutual relationship

    Parkinson’s disease (PD) usually occurs due to the degeneration of dopaminergic neurons in the substantia nigra (SN). Management of PD is restricted...

    Mohammed Alrouji, Hayder M. Al-kuraishy, ... Gaber El-Saber Batiha in Pharmacological Reports
    Article 03 June 2023
  9. Pharmacokinetics and tissue distribution of hydrazinocurcumin in rats

    Background

    Curcumin, a natural polyphenol from Curcuma longa, is known to possess diversified pharmacological roles including anti-inflammatory,...

    Satyavert, Sumeet Gupta, ... Kavita Munjal in Pharmacological Reports
    Article 20 July 2021
  10. Lurasidone in schizophrenia in adolescents: a profile of its use

    The second-generation (atypical) antipsychotic lurasidone (Latuda ® ) presents a useful option to consider for the treatment of schizophrenia in...

    Article 03 August 2021
  11. Suramin enhances the urinary excretion of VEGF-A in normoglycemic and streptozotocin-induced diabetic rats

    Background

    Vascular endothelial growth factor A (VEGF-A) and P2-receptors (P2Rs) are involved in the pathogenesis of diabetic nephropathy. The...

    Gabriela Chyła, Kornelia Sałaga-Zaleska, ... Maciej Jankowski in Pharmacological Reports
    Article Open access 26 February 2021
  12. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts

    Statins are inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme in cholesterol biosynthesis, that are highly effective in reducing...

    Carolina Dagli-Hernandez, Yitian Zhou, ... Rosario Dominguez Crespo Hirata in Pharmacological Reports
    Article 17 August 2021
  13. Pharmacological Effects, Pharmacokinetics, and Strategies to Reduce Brucine Toxicity

    Semen strychni , the seed of Strychnos nux-vomica L., Loganiaceae, has been widely used in China for a long history. Brucine, one of the main...

    Liang Zhang, Wenying Yu in Revista Brasileira de Farmacognosia
    Article 22 December 2021
  14. Impact of selected genetic factors on clopidogrel inactive metabolite level and antiplatelet response in patients after percutaneous coronary intervention

    Background and objective

    Clopidogrel is frequently used as part of optimal dual antiplatelet therapy in high-bleeding risk patients with the acute...

    Urszula Adamiak-Giera, Anna Czerkawska, ... Barbara Gawrońska-Szklarz in Pharmacological Reports
    Article Open access 03 December 2020
  15. Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehicles

    Gastric cancer (GC) is one of the most prevalent malignancies in the world, with a high mortality rate in both women and men. Conventional...

    Maryam Dolatshahi, Ahmad Reza Bahrami, ... Maryam M. Matin in Archives of Pharmacal Research
    Article 27 December 2023
  16. IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn’s disease and new therapeutic targets

    Ulcerative colitis (UC) and Crohn’s disease (CD) are chronic and multifactorial diseases that affect the intestinal tract, both characterized by...

    Doha Anka Idrissi, Nezha Senhaji, ... Younes Zaid in Archives of Pharmacal Research
    Article 04 January 2021
  17. Molecular-Genetic Basis of Gastrointestinal Stromal Tumor Personalized Therapy by Receptor Tyrosine Kinase Inhibitors (A Review)

    Studies of the pharmacotherapy of gastro-intestinal stromal tumor as examples of personalized medicine are reviewed. Peculiarities of the use of...

    M. T. Kozinova, G. A. Abalakov, ... N. L. Shimanovsky in Pharmaceutical Chemistry Journal
    Article 23 July 2021
  18. Characterization of a mouse neuropathic pain model caused by the highly active antiviral therapy (HAART) Stavudine

    Background

    Although highly active antiviral therapies (HAART) exert control over viral replication in persons with Acquired Immunodeficiency Syndrome...

    Jenny L. Wilkerson, Jasmine S. Felix, ... Lance R. McMahon in Pharmacological Reports
    Article 16 April 2021
  19. Recycling Preparative Liquid Chromatography, the Overlooked Methodology for the Purification of Natural Products

    Frequently, preparative high-performance liquid chromatography separations of complex natural product mixtures by adsorption chromatography are...

    Rogelio Pereda-Miranda, Jhon F. Castañeda-Gómez, Mabel Fragoso-Serrano in Revista Brasileira de Farmacognosia
    Article Open access 10 June 2024
  20. Gout plus cardiovascular disease is painful, but treatable

    Gout often coexists with and worsens cardiovascular disease (CVD) or CVD risk factors. Effective gout management reduces CVD deterioration, which...

    Caroline Fenton, Arnold Lee in Drugs & Therapy Perspectives
    Article 18 August 2021
Did you find what you were looking for? Share feedback.